טוען...
Combined Varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokers
Heavy drinking smokers constitute a distinct sub-population of smokers for whom traditional smoking cessation therapies may not be effective. Recent evidence suggested that combined varenicline (VAR) and naltrexone (NTX) therapy may be more efficacious than either monotherapy alone in reducing smoki...
שמור ב:
| הוצא לאור ב: | Pharmacol Biochem Behav |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4457679/ https://ncbi.nlm.nih.gov/pubmed/25933795 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pbb.2015.04.013 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|